Gene · 375790
Papers3,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and functional exploration of hub genes related to energy metabolism in acute myeloid leukemia. | Hematology | 2026 | 41769961 | PubTator, text mining | PubMed |
| The Relationship Between Immune Semaphorins and Myasthenia Gravis. | Brain Behav | 2026 | 41761565 | PubTator, text mining | PubMed |
| Structure and Function of Ocular Proteoglycans: Essential Proteins for Vision. | Int J Mol Sci | 2026 | 41752079 | PubTator, text mining | PubMed |
| Spatiotemporal Remodeling of Presynaptic Terminals in Human Neuromuscular Junctions. | Int J Mol Sci | 2026 | 41752064 | PubTator, text mining | PubMed |
| Mapping the Brain's Glymphatic System. | Biomedicines | 2026 | 41751308 | PubTator, text mining | PubMed |
| A New Cardiac Decellularized Extracellular Matrix (dECM)-Based Hydrogel: From Its Development with a Standardized Myocardial Decellularization Procedure to In Vitro Model Applications. | Gels | 2026 | 41744987 | PubTator, text mining | PubMed |
| The Oncogenic Role of Long Non-Coding RNA NEAT1 in Head and Neck Squamous Cell Carcinoma: From Molecular Mechanisms to Clinical Implications. | Biology (Basel) | 2026 | 41744616 | PubTator, text mining | PubMed |
| DNER as a novel protein contributes to HSCR pathogenesis: multi-omics combined Mendelian randomization analysis. | Pediatr Res | 2026 | 41741780 | PubTator, text mining | PubMed |
| Telitacicept for refractory AChR-positive generalized myasthenia gravis: a retrospective real-world study. | Front Immunol | 2026 | 41737228 | PubTator, text mining | PubMed |
| 3D Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion. | bioRxiv | 2026 | 41726908 | PubTator, text mining | PubMed |
| Low Prevalence and Inconsistency of LRP4-IgG Detection in Suspected Myasthenia Gravis: A Multicenter CBA Comparison. | Neurol Neuroimmunol Neuroinflamm | 2026 | 41719501 | PubTator, text mining | PubMed |
| Exercise during 14 days of head down tilt bedrest attenuates motor unit impairments in older humans. | Exp Physiol | 2026 | 41719153 | PubTator, text mining | PubMed |
| Neuromuscular Mechanisms and Oxidative Stress in Skeletal Muscle Atrophy: Emerging Stem Cell and Gene-Based Therapeutic Strategies. | Muscles | 2026 | 41718080 | PubTator, text mining | PubMed |
| Extracellular vesicles at the neuromuscular junction: messengers of synaptic health and disease. | Cell Tissue Res | 2026 | 41686369 | PubTator, text mining | PubMed |
| Agrin at the crossroads of aging: A pleiotropic regulator in age-related diseases. | Pharmacol Res | 2026 | 41654149 | PubTator, text mining | PubMed |
| Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions. | Mol Diagn Ther | 2026 | 41619083 | PubTator, text mining | PubMed |
| Comparative efficacy of different interventions on circulating factors in sarcopenia individuals: a systematic review and network meta-analysis. | Aging Clin Exp Res | 2026 | 41619066 | PubTator, text mining | PubMed |
| Targeted blood proteome profiling using NULISAseq identifies a high-performance biomarker panel for Aβ pathology quantification and staging. | Alzheimers Dement | 2026 | 41612914 | PubTator, text mining | PubMed |
| Exploring Pembrolizumab-Induced IM3OS in a Patient With Bladder Cancer. | Pharmacol Res Perspect | 2026 | 41582708 | PubTator, text mining | PubMed |
| Calprotectin Is a Circulating Biomarker and Potential Therapeutic Target for Sarcopenia in Chronic Obstructive Pulmonary Disease. | J Cachexia Sarcopenia Muscle | 2026 | 41582634 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/375790/papers?page=3